Daniel Senfter

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Co-targeting CDK4/6 and MEK reverses mesenchymal transition in therapy-refractory BRAF-altered pediatric high-grade glioma.

Co-targeting CDK4/6 and MEK reverses mesenchymal transition in therapy-refractory BRAF-altered pediatric high-grade glioma.

Journal: Journal of experimental & clinical cancer research : CR
Published: January 28, 2026

Tumor-suppressive role of miR-216b impacts cell cycle regulation in high-grade glioma.

Tumor-suppressive role of miR-216b impacts cell cycle regulation in high-grade glioma.

Journal: Acta neuropathologica communications
Published: September 29, 2025

M-PACT leverages cell-free DNA methylomes to achieve robust classification of pediatric brain tumors.

M-PACT leverages cell-free DNA methylomes to achieve robust classification of pediatric brain tumors.

Journal: Nature cancer
Published: March 10, 2025

Alternative lengthening of telomere-based immortalization renders H3G34R-mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimens.

Alternative lengthening of telomere-based immortalization renders H3G34R-mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimens.

Journal: Neuro-oncology
Published: November 18, 2024

Detection of H3F3A K27M or BRAF V600E in liquid biopsies of brain tumor patients as diagnostic and monitoring biomarker: impact of tumor localization and sampling method.

Detection of H3F3A K27M or BRAF V600E in liquid biopsies of brain tumor patients as diagnostic and monitoring biomarker: impact of tumor localization and sampling method.

Journal: Acta neuropathologica
Published: October 07, 2024

Cellular hierarchies of embryonal tumors with multilayered rosettes are shaped by oncogenic microRNAs and receptor-ligand interactions.

Cellular hierarchies of embryonal tumors with multilayered rosettes are shaped by oncogenic microRNAs and receptor-ligand interactions.

Journal: Nature cancer
Published: August 24, 2024

Effective targeting of PDGFRA-altered high-grade glioma with avapritinib.

Effective targeting of PDGFRA-altered high-grade glioma with avapritinib.

Journal: Cancer cell
Published: July 30, 2024

Distribution of Bevacizumab into the Cerebrospinal Fluid of Children and Adolescents with Recurrent Brain Tumors.

Distribution of Bevacizumab into the Cerebrospinal Fluid of Children and Adolescents with Recurrent Brain Tumors.

Journal: Paediatric drugs
Published: March 04, 2024

Proof-of-Concept for Liquid Biopsy Disease Monitoring of MYC-Amplified Group 3 Medulloblastoma by Droplet Digital PCR.

Proof-of-Concept for Liquid Biopsy Disease Monitoring of MYC-Amplified Group 3 Medulloblastoma by Droplet Digital PCR.

Journal: Cancers
Published: March 04, 2023

Clinical applicability of miR517a detection in liquid biopsies of ETMR patients.

Clinical applicability of miR517a detection in liquid biopsies of ETMR patients.

Journal: Acta neuropathologica
Published: January 10, 2023

Targeting DNA repair to enhance the efficacy of sorafenib in hepatocellular carcinoma.

Targeting DNA repair to enhance the efficacy of sorafenib in hepatocellular carcinoma.

Journal: Journal of cellular biochemistry
Published: December 20, 2021

Cytotoxic Activity of Piperazin-2-One-Based Structures: Cyclic Imines, Lactams, Aminophosphonates, and Their Derivatives.

Cytotoxic Activity of Piperazin-2-One-Based Structures: Cyclic Imines, Lactams, Aminophosphonates, and Their Derivatives.

Journal: Materials (Basel, Switzerland)
Published: March 21, 2021
Showing 1-12 of 25

Last Updated: 09/26/2026